Home
About
Overview
Sharing Data
ORCID
Help
History (41)
King, Andrea
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
Genetic testing for susceptibility to cancer. Task Force on Cancer Genetics Education.
Novel diagnostic and prognostic modalities in inflammatory bowel disease.
Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
See All 41 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
Clinical scenarios in IBD: optimizing the use of conventional and biologic agents. Inflamm Bowel Dis. 2010 Dec; 16 Suppl 1:S1-11.
View in:
PubMed
subject areas
Anti-Inflammatory Agents
Biological Products
Clinical Trials as Topic
Congresses as Topic
Humans
Inflammatory Bowel Diseases
authors with profiles
Stephen B. Hanauer
David Rubin